Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months

por Sparabombe, Scilla, Vitali, Lucia, Nori, Alessandra, Berlin, Ricarda Sara, Mazur, Marta, Orsini, Giovanna, Putignano, Angelo
Publicado 2014